SETTLING UGDP CONTROVERSY

被引：25

作者：

BRADLEY, RF ^{[1
]}

DOLGER, H ^{[1
]}

FORSHAM, PH ^{[1
]}

SELTZER, H ^{[1
]}

机构：

[1] COMMITTEE CARE DIABET,170 PILGRIM RD,BOSTON,MA 02215

来源：

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 1975年 / 232卷 / 08期

关键词：

D O I：

10.1001/jama.232.8.813

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：813 / 817

页数：5

共 57 条

[1] PATHOLOGICAL FINDINGS AFTER LONG-TERM SULFONYLUREA THERAPY
BALODIMOS, MC
MARBLE, A
RIPPEY, JH
LEGG, MA
KUWABARA, T
GLEASON, RE
[J]. DIABETES, 1968, 17 (08) : 503 - +
[2] BALODIMOS MC, 1967, 1967 BROOK LODG S TO
[3] BALODIMOS MC, 1971, 7TH C INT DIAB FED B, P15
[4] THE ELECTROCARDIOGRAM IN POPULATION STUDIES - A CLASSIFICATION SYSTEM
BLACKBURN, H
KEYS, A
SIMONSON, E
RAUTAHARJU, P
PUNSAR, S
[J]. CIRCULATION, 1960, 21 (06) : 1160 - 1175
[5] BOYLE D, 1972, LANCET, V1, P338
[6] BRADLEY RF, 1974, CONTROVERSY INTERNAL, P404
[7] CARLSTROM S, 1974, ACTA ENDOCRINOL-COP, V77, P7
[8] SETTLING UGDP CONTROVERSY
CHALMERS, TC
[J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1975, 231 (06): : 624 - 625
[9] COLWELL JA, 1971, DIABETES MELLITUS DI, P153
[10] IS USE OF SULPHONYLUREA DERIVATIVES IN TREATMENT OF DIABETES MELLITUS DANGEROUS
CONSTAM, GR
[J]. DIABETOLOGIA, 1971, 7 (04) : 237 - &